Back
L3Harris Technologies Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Buy
77
LHX
L3Harris Technologies
Last Price:
$230.21
Seasonality Move:
1.22%
Buy
55
RYTM
Rhythm Pharmaceuticals
Last Price:
$59.94
Seasonality Move:
84.98%
Buy
77
L3Harris Technologies (LHX)
is a Buy
Is L3Harris Technologies a Buy, Sell or Hold?
-
The current L3Harris Technologies [LHX] share price is $226.86. The Score for LHX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
-
LHX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
55
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals [RYTM] share price is $60.18. The Score for RYTM is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LHX Stock Price Chart
What is L3Harris Technologies's stock price today?
-
The L3Harris Technologies share price today is $226.86Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LHX is experiencing buying pressure, which is a positive indicator for future bullish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $60.18The current trend is relatively stagnant and RYTM is experiencing selling pressure, which indicates risk of future bearish movement.
LHX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.07 | Buy |
Relative Strength Index (14 RSI): | 68.04 | Buy |
Chaikin Money Flow: | 1481369 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
RYTM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.24 | Buy |
Relative Strength Index (14 RSI): | 50.66 | Buy |
Chaikin Money Flow: | 683641 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
LHX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 219.48 | Buy |
20-day SMA: | 218.51 | Buy |
50-day SMA: | 214.67 | Buy |
200-day SMA: | 224.87 | Buy |
8-day EMA: | 220.58 | Buy |
20-day EMA: | 218.54 | Buy |
50-day EMA: | 215.82 | Buy |
200-day EMA: | 218.75 | Buy |
RYTM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 59.83 | Buy |
20-day SMA: | 61.69 | Sell |
50-day SMA: | 57.05 | Buy |
200-day SMA: | 54.4 | Buy |
8-day EMA: | 59.69 | Buy |
20-day EMA: | 60.27 | Sell |
50-day EMA: | 58.68 | Buy |
200-day EMA: | 53.81 | Buy |
L3Harris Technologies Earnings Growth & LHX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.55 per share, an increase next quarter of $0.23 per share, a decrease this year of $2.59 per share, and an increase next year of $1.66 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.17 per share, an increase this year of $1.44 per share, and an increase next year of $1.20 per share.
L3Harris Technologies Technical Analysis
May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Rhythm Pharmaceuticals Technical Analysis
May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |